Erectile dysfunction in chronic prostatitis – the problem of the myth?
##plugins.themes.bootstrap3.article.main##
Abstract
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
http://uroweb.org/individual-guidelines/non-oncology-guidelines/
Fisher W.A., et al. Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med, 2009. 6: 2746.
Hatzimouratidis K., et al., EAU Guidelines Panel on Male Sexual Dysfunction. EAU guidelines on Male Sexual Dysfunction. Edn. presented at the EAU Annual Congress Munich 2016.
Braun M., Wassmer G., Klotz T. et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000 Dec;12(6):305–11.
Юнда И.Ф. Болезни мужских половых органов. – К.: Здоров’я, 1989. – 272 с.
Сексология и андрология/ Под ред. Возианова А.Ф., Горпинченко И.И./ Бойко Н.И., Борисенко Ю.А., Быстров А.А. и др. – К.: Абрис, 1997. – 880 с.
Абу Сeлех А., Зайцев В.І., Iлюк I.I., Святська Л.В. Сучасні аспекти колонізації органів сечостатевої системи чоловіків при хронічному запальному процесі // Клінічна та експериментальна патологія. – 2006. – No 1. – С. 40–45.
Тиктинский О.Л., Калинина С.Н. Хламидийный простатит. – СПб: Питер. – 2001. – 267 c.
Schouten B.W., et al. Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of followup in the Krimpen Study. Int J Impot Res, 2005. 17: 58.
Besiroglu H., et al. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med, 2015. 12: 1309.
Seftel A.D., et al. Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data. Int J Clin Pract, 2013. 67: 32.
Boyle P., Robertson C., Lowe F., et al. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia// Urology. 2000, 55(4). – Р. 533–539.
Avins AL, Bent S. Saw palmetto and lower urinary tract symptoms: what is the latest evidence? Curr Urol Rep. 2006, 7(4). – Р. 260–5.
Tacklind J., MacDonald R., Rutks I., Wilt T.J. Serenoa repens for benign prostatic hyperplasia
/Cochrane Database of Systematic Reviews (Online). – 2009. – http://ukpmc.ac.uk/abstract/MED/19370565.